We are live on ! Find out more
Mirae Asset Global Investments

Mirae Asset Global Investments Portfolio holdings

AUM $67.7B
1-Year Est. Return 51.91%
This Fund
S&P 500
This Quarter Est. Return
+8.77%
1 Year Est. Return
+51.91%
3 Year Est. Return
+141.83%
5 Year Est. Return
+190.65%
10 Year Est. Return
+978.24%
AUM
$35.8B
AUM Growth
+$7B
Cap. Flow
+$4.91B
Cap. Flow %
13.7%
Top 10 Hldgs %
15.21%
Holding
1,769
New
246
Increased
1,010
Reduced
412
Closed
75

Sector Composition

Rank Sector Weight
1 Technology 23.86%
2 Industrials 10.44%
3 Consumer Discretionary 9.46%
4 Materials 8.1%
5 Healthcare 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEON icon
1676
VEON
VEON
$3.9B
$65K ﹤0.01%
1,424
+295
+26% +$13K
ALKS icon
1677
Alkermes
ALKS
$8.26B
$64K ﹤0.01%
+2,609
New +$58K
OIBR.C
1678
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$64K ﹤0.01%
42,905
+8,869
+26% +$13.7K
OPK icon
1679
Opko Health
OPK
$1.04B
$44K ﹤0.01%
10,896
+217
+2% +$851
CLVT icon
1680
Clarivate
CLVT
$1.22B
$40K ﹤0.01%
+1,437
New +$39.5K
PRTA icon
1681
Prothena Corp
PRTA
$473M
$37K ﹤0.01%
+718
New +$22.4K
NEW
1682
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
$19K ﹤0.01%
1,081
-239
-18% -$6.58K
ENDP
1683
DELISTED
Endo International plc
ENDP
$18K ﹤0.01%
+3,793
New +$21.7K
AFMD
1684
DELISTED
Affimed
AFMD
$16K ﹤0.01%
+193
New +$17.6K
CGEN icon
1685
Compugen
CGEN
$221M
$11K ﹤0.01%
+1,360
New +$11K
MGTX icon
1686
MeiraGTx Holdings
MGTX
$1.21B
$11K ﹤0.01%
+720
New +$10.3K
ACIU icon
1687
AC Immune
ACIU
$259M
$9K ﹤0.01%
+1,181
New +$8.16K
HTPA
1688
DELISTED
Highland Transcend Partners I Corp.
HTPA
$8K ﹤0.01%
+799
New +$7.85K
KNSA icon
1689
Kiniksa Pharmaceuticals
KNSA
$6.07B
$7K ﹤0.01%
+526
New +$7.99K
URGN icon
1690
UroGen Pharma
URGN
$2.3B
$6K ﹤0.01%
+363
New +$6.56K
GMDA
1691
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$6K ﹤0.01%
+962
New +$6.63K
KMDA icon
1692
Kamada
KMDA
$409M
$4K ﹤0.01%
+727
New +$4.35K
RVLP
1693
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$3K ﹤0.01%
+1,020
New +$3.12K
ALSN icon
1694
Allison Transmission
ALSN
$10.3B
-7,259
Closed -$296K
ARKG icon
1695
ARK Genomic Revolution ETF
ARKG
$1.79B
-8,900
Closed -$790K
ARKQ icon
1696
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.07B
-6,100
Closed -$512K
BCH icon
1697
Banco de Chile
BCH
$20.7B
-8,976
Closed -$212K
CDXS icon
1698
Codexis
CDXS
$159M
-377,809
Closed -$8.65M
CGNT icon
1699
Cognyte Software
CGNT
$692M
-7,826
Closed -$218K
DAX icon
1700
Global X DAX Germany ETF
DAX
$236M
-6,223
Closed -$203K

Similar funds

Mirae Asset Global Investments's Q2 2021 Portfolio in Review

As of Q2 2021, Mirae Asset Global Investments held 1,769 positions worth $35.8B, up 24% from $28.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Mirae Asset Global Investments deployed $4.91B of net new capital in Q2 2021, opening 246 new positions and adding to 1,010 existing holdings. Its largest new stake was Wheaton Precious Metals: 7,498,440 shares worth $330M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $102M trimmed.

  • Mirae Asset Global Investments's largest Q2 2021 buy was Wheaton Precious Metals: 7,498,440 shares worth $330M.
  • Mirae Asset Global Investments added most to Microsoft in Q2 2021, an estimated $225M increase.
  • Mirae Asset Global Investments's biggest Q2 2021 reduction was Alibaba, cutting an estimated $102M.
  • Mirae Asset Global Investments fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $52.1M.
  • Mirae Asset Global Investments's ten largest holdings make up 15% of its $35.8B portfolio in Q2 2021.
  • Mirae Asset Global Investments opened 246 new positions and closed 75 in Q2 2021.
  • Mirae Asset Global Investments's portfolio value rose 24% quarter-over-quarter to $35.8B.

Based on Mirae Asset Global Investments's 13F filing for Q2 2021, filed 11 Aug 2021.